Vantage Consulting Group Inc Vertex Pharmaceuticals Inc Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $34,567 - $42,726	-88 Reduced 15.28%	488 $228,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $36,692 - $40,147	-90 Reduced 13.51%	576 $240,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $4,116 - $4,928	-12 Reduced 1.77%	666 $270,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $4,058 - $4,349	-12 Reduced 1.74%	678 $235,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $45,590 - $51,026	-145 Reduced 17.37%	690 $242,000
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $17,843 - $20,355	63 Added 8.16%	835 $263,000
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $29,433 - $33,112	-103 Reduced 11.77%	772 $222,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $19,168 - $21,387	-70 Reduced 7.41%	875 $253,000
Q2 2022 Aug 09, 2022	SELL	$234.96 - $292.55 $6,343 - $7,898	-27 Reduced 2.78%	945 $266,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $61,997 - $73,071	-280 Reduced 22.36%	972 $254,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $7,080 - $8,938	-40 Reduced 3.1%	1,252 $275,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $20,859 - $23,343	115 Added 9.77%	1,292 $234,000
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $220,675 - $260,234	1,177 New	1,177 $237,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $66,660 - $77,701	-322 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $66,657 - $88,900	322 New	322 $76,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.